Sunnybrook Research Institute:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sunnybrook Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11220
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sunnybrook Research Institute (SRI) an educational institute that offers medical education and research services. The institute provides undergraduate, postgraduate and doctoral degree programs. It provides research platforms for biological sciences, evaluative clinical sciences and physical sciences. SRI offers research programs for brain science, bone and joint, cancer, heart, rehabilitation, veterans, and women’s and babies. The institute provides laboratory for biomarker imaging research, biophotonics and bioengineering, bulbar function, burn research and skin, cognitive neurology and others. It operates Breast Cancer Research Centre, HOPE Research Center, Perioperative Brain Health Center. SRI is headquartered in Toronto, Ontario, Canada.

Sunnybrook Research Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sunnybrook Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sunnybrook Research Institute, Medical Devices Deals, 2012 to YTD 2018 9
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Neovacs Enters into Agreement with Sunnybrook Research Institute 11
Triphase Accelerator Enters into Agreement with Sunnybrook Research Institute 12
Kalgene Pharma Enters into Co-Development Agreement with Sunnybrook Research Institute, CIMTEC and OCBN 13
Sunnybrook Research Institute – Key Competitors 14
Sunnybrook Research Institute – Key Employees 15
Sunnybrook Research Institute – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Key Facts 2
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sunnybrook Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sunnybrook Research Institute, Deals By Therapy Area, 2012 to YTD 2018 8
Sunnybrook Research Institute, Medical Devices Deals, 2012 to YTD 2018 9
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Neovacs Enters into Agreement with Sunnybrook Research Institute 11
Triphase Accelerator Enters into Agreement with Sunnybrook Research Institute 12
Kalgene Pharma Enters into Co-Development Agreement with Sunnybrook Research Institute, CIMTEC and OCBN 13
Sunnybrook Research Institute, Key Competitors 14
Sunnybrook Research Institute, Key Employees 15
Sunnybrook Research Institute, Subsidiaries 16

List of Figures
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sunnybrook Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sunnybrook Research Institute, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Sunnybrook Research Institute:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Goldman Sachs Group Inc:戦略・SWOT・企業財務分析
    Goldman Sachs Group Inc - Strategy, SWOT and Corporate Finance Report Summary Goldman Sachs Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Taiga Building Products Ltd (TBL):企業の戦略的SWOT分析
    Taiga Building Products Ltd (TBL) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Pinnacle West Capital Corporation:企業の戦略・SWOT・財務分析
    Pinnacle West Capital Corporation - Strategy, SWOT and Corporate Finance Report Summary Pinnacle West Capital Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • National Thermal Power Corporation Ltd:企業の戦略・SWOT・財務分析
    National Thermal Power Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary National Thermal Power Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • CIGNA Corporation:企業の戦略・SWOT・財務情報
    CIGNA Corporation - Strategy, SWOT and Corporate Finance Report Summary CIGNA Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • China National Chemical Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary China National Chemical Corp (ChemChina) is a state-owned enterprise that develops and markets chemicals. The company offers chemical materials and specialty chemicals, agrochemicals, oil processing and refining products, basic chemicals, and rubber products. ChemChina also manufactures equi …
  • Bangkok Dusit Medical Services PCL (BDMS):企業の財務・戦略的SWOT分析
    Bangkok Dusit Medical Services PCL (BDMS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Qliance Medical Management Inc-製薬・医療分野:企業M&A・提携分析
    Summary Qliance Medical Management Inc (QMMI), a subsidiary of Qliance Medical Group is a healthcare service provider that provides primary and preventive care services. The company offers services such as health and wellness, chronic condition management, specialist care coordination, urgent care, …
  • Camel-IDS NV-製薬・医療分野:企業M&A・提携分析
    Summary Camel-IDS NV (Camel-IDS) is a biotechnology company which develops targeted radionuclide therapeutic solutions for the treatment of cancer. The company focuses on developing its lead compound radiopharmaceutical drug for treatment of Her2 positive cancer. Its technology platform is based on …
  • GISA GmbH:企業の戦略的SWOT分析
    GISA GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Genocea Biosciences Inc (GNCA):企業の財務・戦略的SWOT分析
    Summary Genocea Biosciences Inc (Genocea), formerly Genocea Inc is a biopharmaceutical company develops targeted vaccines and immunotherapies for the treatment of cancer. The company’s pipeline products include Gen-009 and Gen-010, a neoantigen cancer vaccine; Gen-011 is an adoptive T cell therapy. …
  • Enzo Clinical Labs Inc-医療機器分野:企業M&A・提携分析
    Summary Enzo Clinical Labs Inc (Enzo Clinical), a subsidiary of Enzo Biochem Inc is a medical laboratory that offers testing services. The laboratory develops technologies in the areas of gene regulation and gene modification, biomedical and pharmaceutical research markets. It offers physicians seve …
  • Bonavista Energy Corp (BNP):企業の財務・戦略的SWOT分析
    Bonavista Energy Corp (BNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • CivaTech Oncology Inc:医療機器:M&Aディール及び事業提携情報
    Summary CivaTech Oncology Inc (CivaTech) is a medical device company that provides radiation therapy solutions. The company develops polymer based low dose rate (LDR) brachytherapy devices for the treatment of cancer. Its product portfolio includes CivaString, a radiation therapy device to treat sol …
  • Eastman Chemical Co (EMN):企業の財務・戦略的SWOT分析
    Eastman Chemical Co (EMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Harley-Davidson Inc (HOG):企業の財務・戦略的SWOT分析
    Harley-Davidson Inc (HOG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sea Run Holdings Inc:製品パイプライン分析
    Summary Sea Run Holdings Inc (Sea Run Holdings) is a healthcare solutions provider that discovers and develops innovative reagents and therapeutics. The company’s pipeline products include salmon plasma and salmon fibrin products. Its salmon plasma product provides effective treatment for acute pain …
  • NaviNet Inc:企業の戦略的SWOT分析
    NaviNet Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Kepler Weber SA (KEPL3):企業の財務・戦略的SWOT分析
    Kepler Weber SA (KEPL3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Haldia Petrochemicals Ltd:企業の戦略的SWOT分析
    Haldia Petrochemicals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆